Schedule 13D ownership disclosure
AXOVANT SCIENCES LTD
Security class unavailable · CUSIP: G0750W104
Event date: 2018-06-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 73.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-18-186285
- Form type
- SC 13D
- Filer
- Sio Gene Therapies Inc.
- CIK
- CIK 1636050
- Filed
- Jun 07, 2018
- Reporting period
- Jun 05, 2018
- Description
- Schedule 13D beneficial ownership